Consainsights logo

Implantable Insulin Pump Market Size, Share, Industry Trends and Forecast to 2030

Implantable Insulin Pump Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

1. Market Size & CAGR of Implantable Insulin Pump Market in 2021

The global implantable insulin pump market is anticipated to have a Compound Annual Growth Rate (CAGR) of 5.2% from 2021 to 2027. As a result, the market is projected to reach a value of USD 550 million by the end of 2027.

2. COVID-19 Impact on the Implantable Insulin Pump Market

The outbreak of COVID-19 has significantly impacted the implantable insulin pump market. With the focus on hospital resources for COVID-19 patients, the market faced challenges in terms of production, distribution, and patient access to insulin pump devices.

3. Implantable Insulin Pump Dynamics

The implantable insulin pump market is driven by factors such as the increasing prevalence of diabetes, technological advancements in pump devices, and the growing preference for minimally invasive insulin delivery methods. However, factors like the high cost of devices and limited reimbursement policies pose challenges to market growth.

4. Segments and Related Analysis

The implantable insulin pump market can be segmented based on product type, end-user, and region. Product types include traditional insulin pumps and advanced hybrid closed-loop systems. End-users primarily comprise hospitals, specialty clinics, and home care settings.

5. By Region Analysis

Regionally, North America dominates the implantable insulin pump market due to the high prevalence of diabetes and the presence of key market players in the region. Europe and Asia Pacific follow closely, driven by increasing awareness about diabetes management and improving healthcare infrastructure.

6. Key Market Players and Competitive Landscape

Key players in the implantable insulin pump market include Medtronic, Tandem Diabetes Care, Insulet Corporation, and Roche Diabetes Care. These companies focus on product innovation, strategic partnerships, and geographic expansion to maintain a competitive edge in the market.

7. Recent Happenings in the Implantable Insulin Pump Market

In recent developments, Medtronic launched the MiniMed™ 780G system, a next-generation hybrid closed-loop system for personalized insulin delivery. Tandem Diabetes Care introduced the t:slim X2™ insulin pump with Control-IQ™ technology for automated insulin delivery. These advancements aim to enhance patient outcomes and improve diabetes management.

Frequently Asked Questions (FAQ):